Preventing drug deaths: the role of Primary Care. v1.0

  • Research type

    Research Study

  • Full title

    Understanding the Role and Potential of Primary Care in the Prevention of Drug Deaths post COVID-19

  • IRAS ID

    287852

  • Contact name

    Aileen O'Gorman

  • Contact email

    aileen.ogorman@uws.ac.uk

  • Sponsor organisation

    University of the West of Scotland

  • Clinicaltrials.gov Identifier

    21/SS/0012, South East Scotland REC 01

  • Duration of Study in the UK

    1 years, 1 months, 31 days

  • Research summary

    Background: Reducing drug related deaths is a key priority for the Scottish Government. People living in the most deprived areas of Scotland are at higher risk of death from drug overdoses and other serious health conditions including COVID-19. ‘Deep End’ GPs provide health care for individuals, families and communities in areas of extreme deprivation. They work in partnership with many different professionals and services who are part of a wider complex system of health and social care. However, little is known about their role in the prevention of drug-related deaths and whether COVID-19 has led to opportunities and/or risks for how GPs provide care for people who use drugs.

    Aim of the study: To understand the role of Primary Health Care Teams in preventing drug related deaths in areas of extreme deprivation in order to inform future policy, practice and research.

    Methods: This study design uses mixed methods combining interviews and focus groups with GPs, patients, affected family members and other stakeholders, and systems mapping. We will explore models of care and interventions delivered by two Deep End GP practices — one in Lothian and one in Glasgow. In-depth case studies will illustrate the role and potential of Primary Care in the prevention of drug-related harms and deaths, as well as the impact COVID-19 has had on how GPs provide care for people who use drugs.

    Analysis and dissemination: Information gathered will be analysed and initial results presented at an ‘experts event’ with stakeholders associated with the study to explore responses to the findings. Recommendations will be made to help improve practice and the delivery of Primary Care to people who use drugs and their families. The final report will be presented to the Scottish Drug Deaths Task Force.

  • REC name

    South East Scotland REC 01

  • REC reference

    21/SS/0012

  • Date of REC Opinion

    12 Mar 2021

  • REC opinion

    Further Information Favourable Opinion